The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Metformin: Taking away the candy for cancer?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,253
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 925
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
A crucial role for adipose tissue p53 in the regulation of insulin resistance
Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2014 · Cited by 891
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
Everhart, J. (1995) · JAMA · doi:10.1001/jama.273.20.1605 · Cited by 742
de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010) · BMJ · doi:10.1136/bmj.c2181 · Cited by 702
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Mammalian AMP-activated protein kinase subfamily
Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.611 · Cited by 652
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
Ben Sahra, I., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., Gounon, P., Le Marchand-Brustel, Y., Giorgetti-Peraldi, S., Cormont, M., Bertolotto, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2782 · Cited by 536
Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Self-citationA meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
PI3K/Akt/mTOR pathway as a target for cancer therapy
Morgensztern, D., & McLeod, H. L. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000173476.67239.3b · Cited by 468
Diabetes mellitus and breast cancer
Wolf, I., Sadetzki, S., Catane, R., Karasik, A., & Kaufman, B. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01736-5 · Cited by 422
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Frasca, F., Pandini, G., Sciacca, L., Pezzino, V., Squatrito, S., Belfiore, A., & Vigneri, R. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801969715 · Cited by 410
Puzzles, promises and a cure for ageing
Vijg, J., & Campisi, J. (2008) · Nature · doi:10.1038/nature07216 · Cited by 407
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Insulin and its receptor: structure, function and evolution
De Meyts, P. (2004) · BioEssays · doi:10.1002/bies.20151 · Cited by 345
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Diabetes mellitus and risk of bladder cancer: a meta-analysis
Larsson, S. C., Orsini, N., Brismar, K., & Wolk, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0468-0 · Cited by 304
Hayer‐Zillgen, M., Brüss, M., & Bönisch, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704785 · Cited by 278
Insulin promotion of colon tumors in rats.
Tran, T. T., Medline, A., & Bruce, W. R. (1996) · PubMed · Cited by 275
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Gotlieb, W. H., Saumet, J., Beauchamp, M.-C., Gu, J., Lau, S., Pollak, M. N., & Bruchim, I. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.008 · Cited by 267
Housa, D., Housová, J., Vernerová, Z., & Haluzík, M. (2006) · Physiological Research · doi:10.33549/physiolres.930848 · Cited by 263
Leung, K.-C., Doyle, N., Ballesteros, M., Waters, M. J., & Ho, K. K. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7017 · Cited by 259
Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7499 · Cited by 250
Rozengurt, E., Sinnett-Smith, J., & Kisfalvi, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2229 · Cited by 247
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Goodwin, P. J., Pritchard, K. I., Ennis, M., Clemons, M., Graham, M., & Fantus, I. G. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.060 · Cited by 228
LKB1; linking cell structure and tumor suppression
Hezel, A. F., & Bardeesy, N. (2008) · Oncogene · doi:10.1038/onc.2008.342 · Cited by 228
Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin
Pugeat, M., Crave, J. C., Elmidani, M., Nicolas, M. H., Garoscio-Cholet, M., Lejeune, H., Déchaud, H., & Tourniaire, J. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90310-2 · Cited by 215
Zakikhani, M., Blouin, M.-J., Piura, E., & Pollak, M. N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0763-9 · Cited by 213
High and typical 18F-FDG bowel uptake in patients treated with metformin
Gontier, E., Fourme, E., Wartski, M., Blondet, C., Bonardel, G., Le Stanc, E., Mantzarides, M., Foehrenbach, H., Pecking, A.-P., & Alberini, J.-L. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0563-6 · Cited by 196
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Algire, C., Zakikhani, M., Blouin, M.-J., Shuai, J. H., & Pollak, M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0038 · Cited by 185
Phoenix, K. N., Vumbaca, F., & Claffey, K. P. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9916-5 · Cited by 173
Virtanen, K. A., Hällsten, K., Parkkola, R. K., Janatuinen, T., Lönnqvist, F., Viljanen, T., Rönnemaa, T., Knuuti, J. M., Huupponen, R., Lönnroth, P., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.283 · Cited by 153
Vikan, T., Schirmer, H., Njølstad, I., & Svartberg, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0943 · Cited by 151
Diabetes and Risk of Non-Hodgkin's Lymphoma
Mitri, J., Castillo, J. J., & Pittas, A. G. (2008) · Diabetes Care · doi:10.2337/dc08-1034 · Cited by 142
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Cazzaniga, M., Bonanni, B., Guerrieri‐Gonzaga, A., & DeCensi, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0871 · Cited by 134
The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
Ersoy, C., Kiyici, S. K., Budak, F., Oral, H. B., Güçlü, M., Duran, C., Selimoğlu, H., Ertürk, E., Tuncel, E., & İmamoğlu, Ş. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.02.006 · Cited by 127
Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients
Hjalgrim, H., Frisch, M., Ekbom, A., Kyvik, K. O., Melbye, M., & Green, A. (1997) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1997.tb00004.x · Cited by 127
Insulin-like growth factor-I and cancer risk
Ibrahim, Y. H., & Yee, D. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.01.005 · Cited by 121
Insulin receptors in breast cancer: Biological and clinical role
Papa, V., & Belfiore, A. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03347871 · Cited by 116
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1736 · Cited by 102
Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U., Pedersen, O. B., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0815 · Cited by 101
Insulin-Dependent Regulation of Insulin-Like Growth Factor-Binding Protein-1*
Snyder, D. K., & Clemmons, D. R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1632 · Cited by 98
Hällsten, K., Virtanen, K. A., Lönnqvist, F., Janatuinen, T., Turiceanu, M., Rönnemaa, T., Viikari, J. S. A., Lehtimäki, T. J., Knuuti, J. M., & Nuutila, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01332.x · Cited by 91
Ning, J., & Clemmons, D. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0474 · Cited by 90
Leung, K.-C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4712 · Cited by 87
Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high‐fat diet
Koohestani, N., Tran, T. T., Lee, W., Wolever, T. M. S., & Bruce, W. R. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514604 · Cited by 81
Martı́n-Castillo, B., Dorca, J., Vázquez‐Martín, A., Oliveras‐Ferraros, C., López‐Bonet, E., García, M., del Barco, S., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp494 · Cited by 64
Iozzo, P., Hällsten, K., Oikonen, V., Virtanen, K. A., Parkkola, R. K., Kemppainen, J., Solin, O. H., Lönnqvist, F., Ferrannini, E., Knuuti, J. M., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2069 · Cited by 64
Activation of AMPK is necessary for killing cancer cells and sparing cardiac cells
Shell, S. A., Lyass, L., Trusk, P. B., Pry, K. J., Wappel, R. L., & Bacus, S. S. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6016 · Cited by 59
Vázquez‐Martín, A., Oliveras‐Ferraros, C., del Barco, S., Martı́n-Castillo, B., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn758 · Cited by 58
Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Chao, C., & Page, J. H. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn160 · Cited by 56
Oliveras-Ferraros, C., Vazquez-Martin, A., & Menendez, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8406 · Cited by 52
Diabetes therapy and cancer risk: causal effects and other plausible explanations
Hernández–Díaz, S., & Adami, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1675-2 · Cited by 52
Chlebowski, R. T., Blackburn, G. L., Hoy, M. K., Thomson, C. A., Giuliano, A. E., McAndrew, P., Hudis, C. A., Butler, J., Shapiro, A., Elashoff, R. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.522 · Cited by 51
Metformin in chemically-induced mammary carcinogenesis in rats
Bojková, B., Orendáš, P., Garajová, M., Kassayová, M., Kútna, V., Ahlersová, E., & Ahlers, I. (2009) · Neoplasma · doi:10.4149/neo_2009_03_269 · Cited by 42
AMPK and p53 help cells through lean times
Thoreen, C. C., & Sabatini, D. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.04.009 · Cited by 42
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Stambolic, V., Woodgett, J. R., Fantus, I. G., Pritchard, K. I., & Goodwin, P. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0015-4 · Cited by 42
The androgenic profile of women with non-insulin-dependent diabetes mellitus.
Tok, E. C., Ertunç, D., Evrüke, C., & Dılek, S. (2004) · PubMed · Cited by 38
Metformin, diet and breast cancer: An avenue for chemoprevention
Muti, P. C., Berrino, F., Krogh, V., Villarini, A., Barba, M., Strano, S., & Blandino, G. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9226 · Cited by 35
Clemmons, D. R., Sleevi, M., Allan, G., & Sommer, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2699 · Cited by 34
Mountjoy, K. G., Finlay, G. J., & Holdaway, I. M. (1987) · PubMed · Cited by 32
Metformin, B12, and Enhanced Breast Cancer Response to Chemotherapy
Garcia, A., & Tisman, G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7857 · Cited by 31
Cited by
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.
Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K. R., MacLeod, G., Mis, M., Zimmermann, M., Fradet-Turcotte, A., Sun, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.015 · Cited by 1,571
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566
Dazert, E., & Hall, M. N. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.003 · Cited by 460
Metadata
- Authors
- Jalving, M., Gietema, J. A., Lefrandt, J. D., Jong, S. D., Reyners, A. K. L., Gans, R. O. B., & Vries, E. G. E. D.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 46
- Issue
- 13
- Pages
- 2369-2380
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2011735982
- Cited by
- 380
- References
- 92
- FWCI
- 14.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.